Imprimis Pharmaceuticals - 11 Year Stock Price History | IMMY

Historical daily share prices for Imprimis Pharmaceuticals since 2007 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Imprimis Pharmaceuticals as of August 15, 2018 is 2.87.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.065B $0.027B
Imprimis Pharmaceuticals, Inc. is a pharmaceutical company focused on its proprietary ophthalmology and urology drug formulations. Imprimis recently launched its urology business, which includes a patented formulation to address patients suffering from interstitial cystitis.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $122.654B 18.98
Abbott Laboratories (ABT) United States $111.276B 23.32
Stryker (SYK) United States $62.124B 24.00
Boston Scientific (BSX) United States $46.051B 23.96
Baxter (BAX) United States $37.778B 25.71
Zimmer Biomet Holdings (ZBH) United States $24.917B 16.01
Smith & Nephew SNATS (SNN) United Kingdom $15.439B 0.00
ResMed (RMD) United States $15.234B 30.24
Bio-Rad Laboratories (BIO) United States $9.625B 61.86
Perrigo (PRGO) Ireland $9.529B 13.52
Hill-Rom Holdings (HRC) United States $6.247B 21.19
ICU Medical (ICUI) United States $6.000B 40.66
Canopy Growth (CGC) Canada $5.894B 0.00
Haemonetics (HAE) United States $5.175B 47.22
Insulet (PODD) United States $5.112B 0.00
Agios Pharmaceuticals (AGIO) United States $4.487B 0.00
Neogen (NEOG) United States $4.317B 68.78
Hutchison China MediTech (HCM) China $4.179B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.671B 0.00
NuVasive (NUVA) United States $3.382B 32.08
National Vision Holdings (EYE) United States $3.296B 0.00
Quidel (QDEL) United States $2.733B 56.00
Phibro Animal Health (PAHC) United States $2.018B 29.97
NxStage Medical (NXTM) United States $1.853B 0.00
Cardiovascular Systems (CSII) United States $1.239B 744.80
Eagle Pharmaceuticals (EGRX) United States $1.188B 35.07
AtriCure (ATRC) United States $1.089B 0.00
VAREX IMAGING (VREX) United States $1.086B 17.75
OraSure Technologies (OSUR) United States $1.015B 66.36
Orthofix (OFIX) United States $1.002B 30.51
TG Therapeutics (TGTX) United States $0.969B 0.00
Cerus (CERS) United States $0.958B 0.00
Surmodics (SRDX) United States $0.947B 114.43
Omeros (OMER) United States $0.931B 0.00
Owens & Minor (OMI) United States $0.930B 9.95
MacroGenics (MGNX) United States $0.870B 0.00
LeMaitre Vascular (LMAT) United States $0.705B 33.81
PetIQ (PETQ) United States $0.668B 0.00
Meridian Bioscience (VIVO) United States $0.632B 21.59
Insys Therapeutics (INSY) United States $0.555B 0.00
Evolus (EOLS) United States $0.534B 0.00
Lantheus Holdings (LNTH) United States $0.511B 15.89
NanoString Technologies (NSTG) United States $0.415B 0.00
Cytosorbents (CTSO) United States $0.359B 0.00
Utah Medical Products (UTMD) United States $0.341B 21.97
BioLife Solutions (BLFS) United States $0.338B 0.00
Quanterix (QTRX) United States $0.326B 0.00
Surface Oncology (SURF) United States $0.269B 0.00
Rockwell Medical (RMTI) United States $0.247B 0.00
Chimerix (CMRX) United States $0.206B 0.00
Fonar (FONR) United States $0.168B 10.19
Chembio Diagnostics (CEMI) United States $0.163B 0.00
Bovie Medical (BVX) United States $0.158B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.119B 0.00
Female Health (VERU) United States $0.110B 0.00
Trinity Biotech (TRIB) Ireland $0.090B 26.75
United-Guardian (UG) United States $0.086B 18.84
Oramed Pharmaceuticals (ORMP) Israel $0.085B 0.00
Neurotrope (NTRP) United States $0.077B 0.00
InfuSystems Holdings (INFU) United States $0.072B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Valeritas Holdings (VLRX) United States $0.036B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Capricor Therapeutics (CAPR) United States $0.031B 0.00
Akers Biosciences Inc (AKER) United States $0.025B 0.00
Myomo (MYO) United States $0.025B 0.00
Senestech (SNES) United States $0.018B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Cellectar Biosciences (CLRB) United States $0.008B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.003B 0.00